Cargando…
Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion
OBJECTIVES: To fully clarify the role of Mitogen Activated Protein Kinase in the therapeutic response to Sorafenib in Renal Cell Carcinoma as well as the cell death mechanism associated to this kinase inhibitor, we have evaluated the implication of several Mitogen Activated Protein Kinases in Renal...
Autores principales: | Serrano-Oviedo, Leticia, Ortega-Muelas, Marta, García-Cano, Jesús, Valero, María Ll., Cimas, Francisco J., Pascual-Serra, Raquel, Fernandez-Aroca, Diego M., Roche, Olga, Ruiz-Hidalgo, María J., Belandia, Borja, Giménez-Bachs, José M., Salinas, Antonio S., Sanchez-Prieto, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062059/ https://www.ncbi.nlm.nih.gov/pubmed/30048489 http://dx.doi.org/10.1371/journal.pone.0200878 |
Ejemplares similares
-
ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology
por: Ortega‐Muelas, Marta, et al.
Publicado: (2021) -
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story
por: García-Cano, Jesús, et al.
Publicado: (2016) -
ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology
por: Arconada-Luque, Elena, et al.
Publicado: (2022) -
P38 MAPK and Radiotherapy: Foes or Friends?
por: García-Flores, Natalia, et al.
Publicado: (2023) -
Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance
por: García-Cano, Jesús, et al.
Publicado: (2015)